Quantitative prediction of human clearance guiding the development of reltegravir (MK-​0518, isentress) and related HIV integrase inhibitors

Authors
Publication date
1 January 2009
Publisher
'American Society for Pharmacology & Experimental Therapeutics (ASPET)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Archivio della ricerca - Università degli studi di Napoli Federico II

      redirect
      oaioai:www.iris.unina.it:11588/77...
      Last time updated on 01/12/2019